Recall Register

Device recall: Alinity s System software version2.8.0, REF LN 06P16-01, IVD, OEI: (01)00380740138479 The Alinity s System is intended…

Class II FDA enforcement event 89604. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Software error associated with the immunoassay analyzer wash cycle which is using 1 mL of wash buffer instead of the intended 3 mL of wash buffer to wash the exterior of the probe.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Abbott Laboratories, Inc started this device recall on 3 Feb 2022. The firm address in the FDA record is in Irving, TX. FDA put the recall in Class II. FDA event 89604 has 1 product record. The first FDA enforcement report date is 23 Mar 2022. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution: US (nationwide) including states of: AL, CA, GA, IL, IN, MN, MO, NC, OK, PA, RI, SC, TN, TX, WA, WI, MD and countries (OUS) including of: Australia, Austria, Bahrain,…

Recalling firm

Abbott Laboratories, Inc, Irving, TX.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 89604: product records
Recall numberProductQuantityClassStatusReport date
Z-0749-2022Alinity s System software version2.8.0, REF LN 06P16-01, IVD, OEI: (01)00380740138479 The Alinity s System is intended for In Vitro diagnostic use only. The Alinity s System is a highthroughput, fully automated immunoassay analyzer designed to determine the presence of specific antigens and antibodies by using…306 unitsClass IIOngoing23 Mar 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2022
839
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
18

Other events of the firm

Other FDA enforcement events of Abbott Laboratories, Inc
InitiatedProduct (first record)TypeClassRecords
12 Jul 2021Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donor screening, pDeviceClass II1
1 May 2019ARCHITECT C System Mixer - Product Usage: The ARCHITECT Clinical Chemistry System is designed to perform automated chemiDeviceClass II1
2 Jan 2019ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in humanDeviceClass II1
7 Sep 2018APS Accelerator modular systems, 208-230 V-, 50/60 Hz, 1800 VA, IVD, RX, Class 2 Laser Product,DeviceClass II1
28 Aug 2018Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip TechnologDeviceClass II1
18 Jul 2018Abbott ARCHITECT Creatine Kinase, IVD, REF 7D63-21.DeviceClass II2
17 Jul 2018Abbott ARCHITECT c4000 Processing Module, List No. 02P24 - Product Usage: The Abbott ARCHITECT System is intended for InDeviceClass II3
14 Jun 2018CardioMEMS HF System Hospital and Patient Electronics Units: (a) Patient Electronics System, Model CM1100 (b) Hospital EDeviceClass II1
16 May 2018C3 is an in vitro diagnostic assay for the quantitative determination of C3 in human serum or plasma. Antibodies to C3 cDeviceClass II9
8 Dec 2017ARCHITECT c4000 Cuvette Segment, Part #02P75-01/02P24, a component to the ARCHITECT Clinical Chemistry system. There areDeviceClass II3

Abbott Laboratories, Inc: all 18 events

Official channels

Cite this page

Recall Register. FDA enforcement event 89604. https://recallregister.com/fda/ii/89604/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution: US (nationwide) including states of: AL, CA, GA, IL, IN, MN, MO, NC, OK, PA, RI, SC, TN, TX, WA, WI, MD and countries (OUS) including of: Australia, Austria, Bahrain,…
What quantity of product is in FDA event 89604?
The FDA record gives this quantity: 306 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2022 have the same class?
88% of the 839 device events that started in 2022 are in Class II.